← Back to exam page

BPS-Pharmacotherapy – BPS Pharmacotherapy

Loading demo links...

Showing 7–9 of 10 questions

Question 7 (BSP Pharmacotherapy Part 2)

A 68-year-old female patient is admitted to the ICU for acute decompensated heart failure. She is currently intubated due to acute respiratory failure and hypoxia. After intubation, her Richmond Agitation-Sedation Scale (RASS) score is +3, and her Confusion Assessment Method for the ICU (CAM-ICU) is positive for delirium. She denies pain.

Which of the following is the best recommendation for achieving her sedation goal of RASS equals zero?

Answer: D

Select an option, then click Submit answer.

Question 8 (BSP Pharmacotherapy Part 1)

A patient is being discharged on dabigatran, and the pharmacotherapy specialist is counseling the patient's caregiver about the medication. What is the best information to give the caregiver concerning the storage of dabigatran?

Answer: B

Select an option, then click Submit answer.

Question 9 (BSP Pharmacotherapy Part 1)

A pharmacotherapy specialist wishes to investigate the impact of thiazolidinedione therapy on Weight gain. The specialist will determine average body weight immediately before participants begin therapy with pioglitazone and again after they complete 12 weeks of treatment. Which of the following statistical methods is most appropriate for analyzing these data?

Answer: A

Select an option, then click Submit answer.